Aurobindo, Hetero, and Vivimed Class Action Settlements in New York

All Aurobindo, Hetero, and Vivimed class action lawsuits and settlements available to New York residents.

New York residents have 1 active class action settlements involving Aurobindo, Hetero, and Vivimed that they can file claims for right now. Open settlements include $15.2M Valsartan, Losartan and Irbesartan class action settlement.

Class Action Buddy automatically files Aurobindo, Hetero, and Vivimed claims for New York residents in under 60 seconds — no paperwork, no mailing, no proof of purchasey/proof-of-purchase/" style="color:#5D82F2;text-decoration:none;font-weight:500;">proof of purchase needed for most settlements.

About Aurobindo, Hetero, and Vivimed Class Actions in New York

New York residents affected by contaminated blood pressure medications from Aurobindo, Hetero, and Vivimed have specific protections under state consumer laws. New York's General Business Law Article 22-A provides additional remedies beyond federal regulations for defective pharmaceuticals. Aurobindo operates a significant U.S. presence through its New Jersey facilities, serving the broader New York metropolitan area market. Hetero and Vivimed distribute generic medications throughout New York's extensive healthcare network, including major hospital systems and pharmacy chains. The state's robust pharmaceutical distribution infrastructure means these manufacturers' products reached numerous New York consumers. New York residents filing class action claims benefit from the state's six-year statute of limitations for breach of warranty claims, longer than many other states. The $15.2 million Valsartan, Losartan and Irbesartan settlement specifically covers patients who purchased these contaminated medications. New York's consumer protection framework often allows for enhanced damages in pharmaceutical cases, particularly when manufacturers failed to disclose known contamination risks to patients and healthcare providers.

How does New York's consumer protection law affect my Aurobindo, Hetero, or Vivimed claim?

New York's General Business Law provides additional protections beyond federal pharmaceutical regulations. The state's six-year statute of limitations for warranty claims gives New York residents more time to file compared to other states, and the law often allows for enhanced damages when manufacturers concealed contamination risks.

Can New York residents participate in the $15.2 million Valsartan settlement if they bought generic versions?

Yes, New York residents who purchased contaminated Valsartan, Losartan, or Irbesartan medications from Aurobindo, Hetero, or Vivimed are eligible for the settlement. The settlement covers generic versions of these blood pressure medications that contained NDMA and other carcinogenic impurities.

Do I need a New York attorney to file claims against these pharmaceutical companies?

While not required, using a New York-licensed attorney familiar with state pharmaceutical laws can be advantageous. New York's complex consumer protection statutes and the state's extensive pharmaceutical distribution network create unique legal considerations that local attorneys understand better.

Tips for New York Residents Filing Aurobindo, Hetero, and Vivimed Claims

New York residents should gather prescription records from all pharmacies where they purchased Valsartan, Losartan, or Irbesartan medications. Check medication bottle labels for manufacturer names including Aurobindo, Hetero, or Vivimed. Maintain medical records showing any health complications potentially linked to contaminated medications. File claims promptly despite New York's extended statute of limitations, as settlement funds may be distributed on a first-come basis. Contact your prescribing physician to document any medication changes made due to contamination recalls. Keep receipts for additional medical monitoring or treatment costs related to carcinogen exposure, as New York law may allow recovery for these expenses.

More New York Resources